Lyric Pharmaceuticals Secures $20,400,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f7f12728-2b66-419c-9586-47f932799723
Date
3/2/2015
Company Name
Lyric Pharmaceuticals
Mailing Address
601 Gateway Boulevard South San Francisco, CA 94080 USA
Company Description
Lyric is a clinical stage company developing novel gastrointestinal therapeutics for unmet medical needs in the hospital setting.
Website
http://www.lyricpharma.com
Transaction Type
Venture Equity
Transaction Amount
$20,400,000
Transaction Round
Series A
Proceeds Purposes
The current financing will enable the company to perform two clinical studies, including a clinical proof of concept study, in addition to other supportive activities.
M&A Terms
Venture Investor
Venture Investor
Venture Investor